Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

SorinC Jan. 15 at 1:20 AM

$LQDA looking for a re-entry

0 · Reply

buyonthego Jan. 15 at 1:17 AM

$LQDA Here we go. Go Roger. 🍺

0 · Reply

cubie Jan. 14 at 11:40 PM

$LQDA $UTHR when patent ruling, asking for some friends😅

1 · Reply

ElliottwaveForecast Jan. 14 at 10:06 PM

$LQDA broke out and now looks poised to wait for a pullback, offering a potential re-entry as the Elliott Wave structure remains bullish. #LQDA #ElliottWave https://elliottwave-forecast.com/stock-market/lqda-buy-breakout-wait-pullback/

0 · Reply

ElliottwaveForecast Jan. 14 at 9:00 PM

📊 $LQDA – Buy Breakout, Wait for Pullback https://elliottwave-forecast.com/stock-market/lqda-buy-breakout-wait-pullback/ Liquidia Corp (LQDA) has broken out, but Elliott Wave analysis suggests waiting for a pullback before positioning for the next leg higher. #Trading #ElliottWave #MarketUpdate

0 · Reply

PatterBuzz Jan. 14 at 8:04 PM

$LQDA Low attention biotech, asymmetry only matters if volume ignition shows up

0 · Reply

BDE_Worldwide Jan. 14 at 6:35 PM

$LQDA don’t fade..

0 · Reply

stevemano Jan. 14 at 5:49 PM

$LQDA negative earnings !

1 · Reply

ElliottwaveForecast Jan. 14 at 5:17 PM

Do you really know when a breakout is reliable — across any market? Learn the wave sequence behind $LQDA and apply the logic everywhere. Check out this 👉 https://elliottwave-forecast.com/stock-market/lqda-buy-breakout-wait-pullback/ #marketanalysis #elliottwave #trading

1 · Reply

stevemano Jan. 14 at 4:35 PM

$LQDA pump and dump!

1 · Reply

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Nov 19, 2025, 2:38 AM EST - 2 months ago

Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 5, 2025, 6:16 PM EST - 2 months ago

Liquidia Corporation: Heading In The Right Direction

Nov 3, 2025, 12:16 PM EST - 2 months ago

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 8:00 AM EST - 2 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 29, 2025, 2:46 PM EDT - 2 months ago

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Oct 27, 2025, 8:30 AM EDT - 2 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 3 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Aug 27, 2025, 8:30 AM EDT - 5 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 13, 2025, 2:51 PM EDT - 5 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 12, 2025, 2:25 PM EDT - 5 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 12:43 PM EDT - 5 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 6:30 AM EDT - 5 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 30, 2025, 10:40 AM EDT - 7 months ago

What Next For Liquidia After Launch?

Jun 23, 2025, 4:34 PM EDT - 7 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 2, 2025, 6:30 AM EDT - 8 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 11:08 AM EDT - 8 months ago

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 8:00 AM EDT - 8 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 23, 2025, 2:28 PM EDT - 8 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 12, 2025, 6:00 AM EDT - 8 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 10, 2025, 9:29 PM EDT - 8 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 8 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 5, 2025, 4:06 PM EDT - 9 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 2, 2025, 5:28 PM EDT - 9 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 9 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 30, 2025, 9:30 AM EDT - 9 months ago

Arquitos Capital's Largest Holdings For Q1 2025

Apr 1, 2025, 10:33 AM EDT - 10 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 10 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 10 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 11:56 AM EDT - 10 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 6:30 AM EDT - 10 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 11 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Nov 15, 2024, 10:20 AM EST - 1 year ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

SorinC Jan. 15 at 1:20 AM

$LQDA looking for a re-entry

0 · Reply

buyonthego Jan. 15 at 1:17 AM

$LQDA Here we go. Go Roger. 🍺

0 · Reply

cubie Jan. 14 at 11:40 PM

$LQDA $UTHR when patent ruling, asking for some friends😅

1 · Reply

ElliottwaveForecast Jan. 14 at 10:06 PM

0 · Reply

ElliottwaveForecast Jan. 14 at 9:00 PM

0 · Reply

PatterBuzz Jan. 14 at 8:04 PM

$LQDA Low attention biotech, asymmetry only matters if volume ignition shows up

0 · Reply

BDE_Worldwide Jan. 14 at 6:35 PM

$LQDA don’t fade..

0 · Reply

stevemano Jan. 14 at 5:49 PM

$LQDA negative earnings !

1 · Reply

ElliottwaveForecast Jan. 14 at 5:17 PM

1 · Reply

stevemano Jan. 14 at 4:35 PM

$LQDA pump and dump!

1 · Reply

Biocontrol Jan. 14 at 4:31 PM

$LQDA

0 · Reply

MarketPro Jan. 14 at 3:30 PM

$LQDA Chart Update

0 · Reply

lsb1201030758 Jan. 14 at 3:22 PM

$LQDA A thing of beauty...

0 · Reply

Affizle Jan. 14 at 3:20 PM

$MNKD Can any of the Mannkind cheerleaders please explain to me why this stock is still a heaping pile of cow manure and $LQDA is a rocket ship going to da moon? I also made a request to Mannkind's CEO to change the ticker from MNKD to "LOLZ." LOLZ!

1 · Reply

ElliottwaveForecast Jan. 14 at 3:18 PM

$LQDA favors rally in ((5)) targeting 40.90 or higher within January-2026 rally It is bullish in daily extending rally from July-2025 low in impulse sequence. Buyers can wait for pullback to get into trend, explained as https://elliottwave-forecast.com/stock-market/lqda-buy-breakout-wait-pullback/ #Elliottwave #LQDA

0 · Reply

JFais Jan. 14 at 3:16 PM

$LQDA- Now above $40 (& 7% PW for me) Re questions I've been getting on this one, if doubles or triples 2026-2027 re + judge decision + Yutrepia sales acceleration, I'll be a happy long And if for whatever reason adverse decision, at least took partial profits Again, the importance of planning for all scenarios 👍

0 · Reply